Suppr超能文献

卡波姆凝胶与含羧甲基纤维素的人工泪液治疗干眼症疗效的比较评估

A comparative assessment of the efficacy of carbomer gel and carboxymethyl cellulose containing artificial tears in dry eyes.

作者信息

Xiao Qing, Hu Yanhua, Chen Fei, Chen Xiaomin

机构信息

Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

出版信息

J Huazhong Univ Sci Technolog Med Sci. 2008 Oct;28(5):592-5. doi: 10.1007/s11596-008-0523-9. Epub 2008 Oct 10.

Abstract

The present study aimed to compare the clinical efficacy of a 0.4% carbomer gel and 1% carboxymethyl cellulose (CMC) containing artificial tears in treatment of dry eye patients. Sixty subjects with mean age of 45.89 years who had symptoms and signs of dry eye were enrolled in this prospective, investigator-masked and stratified random sampling study. The subjects were divided into two parallel groups with 30 subjects (60 eyes) in each group. One group received carbomer gel, and the other group received 1% CMC containing artificial tears. Subjects received the drops 3 to 4 times or more per day for 3 months. At the first visit time, the precorneal residence time of these two drops was measured. The efficacy was assessed by comparing the subjective symptoms (ocular dryness, foreign body sensation, burning sensation and pain), and the objective test results of tears breakup time, Schirmer's test and corneal fluorescein staining prior to the study and after the treatment. As a result, the ocular residence time of carbomer gel was significantly longer than that of 1% CMC (P<0.001). Most of the primary subjective symptoms and objective test results were improved after treatment in both carbomer gel group and 1% CMC group. As to the improvement of each symptom and objective test result, carbomer gel was more effective than 1% CMC group (P<0.01). In conclusion, carbomer gel had longer precorneal residence time and was more effective than 1% CMC in the treatment of patients with dry eyes.

摘要

本研究旨在比较0.4%卡波姆凝胶和含1%羧甲基纤维素(CMC)的人工泪液治疗干眼患者的临床疗效。本前瞻性、研究者设盲和分层随机抽样研究纳入了60名平均年龄为45.89岁、有干眼症状和体征的受试者。受试者被分为两个平行组,每组30名受试者(60只眼)。一组接受卡波姆凝胶,另一组接受含1% CMC的人工泪液。受试者每天滴眼3至4次或更多次,持续3个月。在首次就诊时,测量这两种滴眼液的角膜前滞留时间。通过比较研究前和治疗后的主观症状(眼干、异物感、烧灼感和疼痛)以及泪膜破裂时间、泪液分泌试验和角膜荧光素染色的客观测试结果来评估疗效。结果,卡波姆凝胶的眼内滞留时间明显长于1% CMC(P<0.001)。卡波姆凝胶组和1% CMC组治疗后大多数主要主观症状和客观测试结果均有改善。在每种症状和客观测试结果的改善方面,卡波姆凝胶比1% CMC组更有效(P<0.01)。总之,卡波姆凝胶角膜前滞留时间更长,在治疗干眼患者方面比1% CMC更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验